Neuromodulation最新文献

筛选
英文 中文
Microelectrode Signals Provide Information Beyond Stereotactic Depth for Subthalamic Nucleus Classification: A Patient-Held-Out Study. 微电极信号提供立体定向深度以外的丘脑下核分类信息:一项病人的研究。
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-09 DOI: 10.1016/j.neurom.2026.09.031
Shachar Zion Shemesh, Zaki Hinnawi, Tomer Maimon, Lior Ungar
{"title":"Microelectrode Signals Provide Information Beyond Stereotactic Depth for Subthalamic Nucleus Classification: A Patient-Held-Out Study.","authors":"Shachar Zion Shemesh, Zaki Hinnawi, Tomer Maimon, Lior Ungar","doi":"10.1016/j.neurom.2026.09.031","DOIUrl":"https://doi.org/10.1016/j.neurom.2026.09.031","url":null,"abstract":"<p><strong>Objectives: </strong>During subthalamic nucleus (STN) deep brain stimulation (DBS), microelectrode recording (MER) helps identify the tissue encountered along the planned trajectory. We examined whether MER adds information beyond the electrode's depth relative to the planned target when classifying recordings from patients not used to develop the models.</p><p><strong>Materials and methods: </strong>We analyzed 4650 recordings from 46 patients, assigned to separate development (28 patients), calibration (eight patients), and test (ten patients) groups. Three models used waveform features, target-relative depth, or both. All models and decision thresholds were fixed before testing. Discrimination was measured by the area under the receiver operating characteristic curve (AUROC), averaged equally across patients; 1.0 indicates perfect discrimination and 0.5 indicates chance.</p><p><strong>Results: </strong>Among 1013 recordings from ten test patients, AUROC was 0.977 (95% CI 0.971-0.983) for signal + depth, 0.957 (95% CI 0.937-0.975) for signal alone, and 0.889 (95% CI 0.848-0.928) for depth alone. Combining signal and depth improved AUROC over depth alone by 0.088 (95% CI 0.051-0.127), with improvement in every patient. At the predefined threshold, sensitivity was 96.8% and specificity was 77.4%. In an exploratory analysis within ±2 mm of the target, AUROC for signal alone remained 0.963, compared with 0.595 for depth alone.</p><p><strong>Conclusions: </strong>MER provided information beyond target-relative depth for classifying source-labeled STN recordings in previously unseen patients. Combining both inputs gave the highest discrimination. These results support further evaluation of quantitative MER as an adjunct to surgical targeting; they do not establish optimal lead placement or improved clinical outcomes.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-Guided Percutaneous Neuromodulation of the Spinal Accessory Nerve as an Adjunct to Exercise Therapy in Acute Whiplash-Associated Disorders: An Assessor-Blinded Randomized Controlled Trial. 超声引导下经皮脊髓副神经调节作为急性鞭伤相关疾病运动治疗的辅助疗法:一项评估盲随机对照试验
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-09 DOI: 10.1016/j.neurom.2026.09.028
Jorge Llanos-López, Fermín Valera-Garrido, Francisco Minaya-Muñoz, Óscar Carvajal-Fernández, David Álvarez-Prats, Alberto Carcasona-Otal, Pablo Herrero, Diego Lapuente-Hernández
{"title":"Ultrasound-Guided Percutaneous Neuromodulation of the Spinal Accessory Nerve as an Adjunct to Exercise Therapy in Acute Whiplash-Associated Disorders: An Assessor-Blinded Randomized Controlled Trial.","authors":"Jorge Llanos-López, Fermín Valera-Garrido, Francisco Minaya-Muñoz, Óscar Carvajal-Fernández, David Álvarez-Prats, Alberto Carcasona-Otal, Pablo Herrero, Diego Lapuente-Hernández","doi":"10.1016/j.neurom.2026.09.028","DOIUrl":"https://doi.org/10.1016/j.neurom.2026.09.028","url":null,"abstract":"<p><strong>Objectives: </strong>This study evaluated the effectiveness of adding ultrasound-guided percutaneous neuromodulation (US-guided PNM) of the spinal accessory nerve to a neck-specific exercise program in acute whiplash-associated disorders (WAD), a common consequence of traffic collisions that is associated with pain and disability. Exercise is recommended as a first-line intervention, but the added benefit of US-guided PNM, a novel intervention targeting neuromuscular function and pain processing, remains unclear.</p><p><strong>Materials and methods: </strong>A short-term, assessor-blinded, superiority randomized controlled trial was conducted. Forty-four participants with grade I-II WAD were allocated to an active control group (exercise) or an experimental group (US-guided PNM + exercise). Both groups received two weekly exercise sessions for three weeks, while the experimental group additionally received one weekly US-guided PNM session. Outcomes were assessed at baseline and at Weeks 1, 2, and 3, with Week 3 being the primary end point, one week after the final US-guided PNM session. Disability, measured with the Neck Disability Index (NDI), was the primary outcome, whereas pain intensity (visual analog scale [VAS]), pressure pain thresholds (PPT), and active cervical range of motion (ROM) were secondary outcomes. Longitudinal changes and between-group differences were evaluated using linear mixed-effects models adjusted for baseline values, with estimated marginal means and 95% CIs reported.</p><p><strong>Results: </strong>At the primary end point (Week 3), both groups improved significantly from baseline in NDI and VAS, with no significant between-group difference (NDI: -1.25 points, 95% CI -4.38 to 1.87, p = 0.427, d = -0.13; VAS: -8.60 mm, 95% CI -17.47 to 0.25, p = 0.057, d = -0.41). PPT was significantly higher in the experimental group at Week 3 on both the treated (mean difference [MD]: 0.26 kg/cm<sup>2</sup>, 95% CI 0.08-0.44, p = 0.005, d = 0.60) and contralateral (MD: 0.27 kg/cm<sup>2</sup>, 95% CI 0.10-0.43, p = 0.002, d = 0.60) sides; however, a significant Group × Time interaction was observed only on the contralateral side (p = 0.035) and not on the treated side (p = 0.201). Active cervical ROM was significantly greater in the experimental group across all six movements at Week 3 (MD: 6.97-11.80 °, d = 0.64-1.13), with a significant Group × Time interaction limited to two of them.</p><p><strong>Conclusions: </strong>Adding US-guided PNM to exercise did not provide additional short-term benefit for self-reported disability or pain intensity compared with exercise alone in acute WAD. PPT and ROM findings warrant confirmation in larger, longer-term, sham-controlled trials.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond the Responder Threshold: Expectations and Psychologic Profiles Among Dorsal Root Ganglion Stimulation Trial Responders Who Did and Did Not Proceed to Implantation-A Prospective Observational Pilot Study. 超过应答者阈值:背根神经节刺激试验应答者是否继续植入的期望和心理特征——一项前瞻性观察性试点研究。
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-09 DOI: 10.1016/j.neurom.2026.09.033
Charles A Odonkor, Corey T Gatewood, Aziz Saade, Ashlyn Brown, Kenneth B Chapman, Dirk De Ridder
{"title":"Beyond the Responder Threshold: Expectations and Psychologic Profiles Among Dorsal Root Ganglion Stimulation Trial Responders Who Did and Did Not Proceed to Implantation-A Prospective Observational Pilot Study.","authors":"Charles A Odonkor, Corey T Gatewood, Aziz Saade, Ashlyn Brown, Kenneth B Chapman, Dirk De Ridder","doi":"10.1016/j.neurom.2026.09.033","DOIUrl":"https://doi.org/10.1016/j.neurom.2026.09.033","url":null,"abstract":"<p><strong>Objectives: </strong>Conversion from a dorsal root ganglion stimulation (DRGS) trial to a permanent implant is conventionally guided by a ≥50% pain-relief responder threshold, yet some patients who meet this threshold do not proceed. We described pretrial expectations and psychologic profiles among responders who did and did not proceed.</p><p><strong>Materials and methods: </strong>This was a prospective observational pilot of 27 consecutive DRGS trial attempts (5-7 days); two were aborted for technical reasons, leaving 25 completed trials. Patients were classified as responder-converters (≥50% relief, implanted), responder nonconverters (≥50% relief, not implanted), or nonresponder nonconverters (<50% relief). Research staff administered expectation (Stanford Expectations of Treatment Scale [SETS]; Treatment Expectations in Chronic Pain [TEC] scale) and psychologic (Patient Health Questionnaire-9 [PHQ-9], Pain Catastrophizing Scale [PCS], and Tampa Scale for Kinesiophobia [11-item] [TSK-11]) measures; implanting physicians did not have access to these scores. Analyses were prespecified as descriptive, with responder-converters vs responder nonconverters as the principal contrast. Reasons for declining implantation were documented prospectively.</p><p><strong>Results: </strong>Seventeen of 25 patients (68%) were responders; 12 were implanted, and five were not implanted. Mean trial relief was similar in the two responder groups (71.7% vs 66.0%). Responder nonconverters had higher median PHQ-9 (18 vs 0), PCS (33 vs 1), and TSK-11 (23 vs 11) scores (Hodges-Lehmann differences of 18, 32, and 12 points) and scores similar to those of nonresponders. TEC ideal and predicted expectations were higher in responder-converters (d = 1.03 and 0.97, with wide intervals); SETS differences were smaller (d = 0.27 and -0.46). All five responder nonconverters declined implantation themselves, citing absent functional or overall improvement, persistent nonpain symptoms, or fear of implantation.</p><p><strong>Conclusions: </strong>In this pilot, responders who did not proceed reported analgesia comparable to converters but substantially greater psychologic symptom burden. These imprecise, hypothesis-generating estimates do not establish causation and should not be used to deny trials or implants to patients with high symptom burden.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149371307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Updated Prospective Quantitative Analysis of Symptoms and Safety for Human Low-Intensity Focused Ultrasound Neuromodulation. 人类低强度聚焦超声神经调节的症状和安全性的最新前瞻性定量分析。
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-09 DOI: 10.1016/j.neurom.2026.09.030
Aditya Kapoor, Thomas Crahan, Wynn Legon
{"title":"An Updated Prospective Quantitative Analysis of Symptoms and Safety for Human Low-Intensity Focused Ultrasound Neuromodulation.","authors":"Aditya Kapoor, Thomas Crahan, Wynn Legon","doi":"10.1016/j.neurom.2026.09.030","DOIUrl":"10.1016/j.neurom.2026.09.030","url":null,"abstract":"<p><strong>Objectives: </strong>Low-intensity focused ultrasound (LIFU) is a noninvasive neuromodulation technique with a favorable safety profile in healthy volunteers. Participant-experienced symptoms, however, remain inconsistently measured, and prospective benchmarks are lacking. Here, we prospectively characterized symptoms associated with LIFU neuromodulation across eight studies using a standardized Report of Symptoms (ROS).</p><p><strong>Materials and methods: </strong>We compiled 629 sessions (472 LIFU and 157 sham) in 106 healthy adults (28.1 ± 9.8 years) across eight cortical and subcortical targets (500 kHz; extracranial spatial-peak pulse-average intensity 3.9-33.3 W/cm<sup>2</sup>; mechanical index 0.5-1.4). The ROS rated 17 symptom domains from 0 (absent) to 3 (severe) before and after each session. New-onset incidence, symptom severity, and total symptom burden were compared between LIFU and sham. The same instrument was applied in 35 patients with chronic pain. Symptom profiles after LIFU were indistinguishable from sham across all 17 domains.</p><p><strong>Results: </strong>The total symptom burden averaged approximately one domain per session and did not increase after LIFU (0.94-1.03; p = 0.120). The postintervention burden was predicted by the baseline burden (β = 0.344, p < 0.001) but not by the stimulation condition (p = 0.226). New-onset symptoms did not increase across up to 27 LIFU sessions (odds ratio = 0.99, p = 0.73) and were weakly and nonsignificantly related to acoustic intensity (ρ = 0.37).</p><p><strong>Conclusion: </strong>Across a prospective, sham-controlled data set, LIFU added no measurable symptom burden and was well tolerated in healthy adults, with comparable tolerability in patients. These findings establish a benchmark for the safety of human LIFU neuromodulation and a foundation for its therapeutic translation.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13744609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149371306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Effects of Subthalamic Deep Brain Stimulation Withdrawal on Response and Movement Speed in Parkinson Disease. 丘脑下深部脑刺激急性停药对帕金森病反应和运动速度的影响。
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-09 DOI: 10.1016/j.neurom.2026.09.032
Dorothee Kübler-Weller, Lisa S Paulsen, Melanie Buth, Elias Landfried, Anna Elsenbach, Patricia Krause, Tina Mainka-Frey, Gregor A Brandt, Bassam Al-Fatly, Andrea A Kühn
{"title":"Acute Effects of Subthalamic Deep Brain Stimulation Withdrawal on Response and Movement Speed in Parkinson Disease.","authors":"Dorothee Kübler-Weller, Lisa S Paulsen, Melanie Buth, Elias Landfried, Anna Elsenbach, Patricia Krause, Tina Mainka-Frey, Gregor A Brandt, Bassam Al-Fatly, Andrea A Kühn","doi":"10.1016/j.neurom.2026.09.032","DOIUrl":"https://doi.org/10.1016/j.neurom.2026.09.032","url":null,"abstract":"<p><strong>Introduction: </strong>Previous studies on deep brain stimulation (DBS) effects on cognition in Parkinson disease (PD) mainly investigated single neuropsychologic domains in isolation and have shown mixed results when comparing performance with stimulation switched on (StimON) and off (StimOFF). We examined short-term effects of subthalamic nucleus (STN)-DBS withdrawal across a comprehensive, standardized neuropsychological battery to characterize which cognitive domains are acutely modulated by stimulation.</p><p><strong>Materials and methods: </strong>In this subanalysis of a prospective cohort study (NCT03982953), 16 patients with PD (five female; age 59.6 ± 10.5 years; disease duration 10.3 ± 5.6 years) completed a tablet-based neuropsychologic battery spanning attention, motor speed, learning, memory, executive function, and social cognition, first during StimON and then, after a 30-minute washout, during StimOFF, with dopaminergic medication kept stable. Twenty one paired comparisons were analyzed with Wilcoxon signed-rank tests (Bonferroni-corrected significance threshold p < 0.0024).</p><p><strong>Results: </strong>StimOFF was associated with significantly slower movement time (p < 0.001) in the simplest reaction-time condition, whereas changes in reaction time with more stimuli (p = 0.004) and multitasking speed (p = 0.031) did not survive correction. Measures of inhibitory control, learning, memory, and social cognition were unchanged in this study.</p><p><strong>Conclusion: </strong>STN-DBS withdrawal slowed reaction time, while broader cognitive domains remained stable, suggesting a predominant effect on attentional and psychomotor speed rather than a broad, domain-general cognitive effect. Given the modest sample size and short washout period, these findings should be regarded as preliminary and warrant confirmation in larger studies with longer washout intervals.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149408878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Closed-Loop Vagus Nerve Stimulation for Poststroke Motor Recovery: A Systematic Review and Meta-Analysis of Movement-Synchronized Neuromodulation. 迷走神经闭环刺激对脑卒中后运动恢复:运动同步神经调节的系统回顾和meta分析。
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-08 DOI: 10.1016/j.neurom.2026.09.026
Majed Aldehri, Ibrahim Serag, Mohamed Farouk, Mohamed M Elgohary, Ibrahim Alnaami
{"title":"Closed-Loop Vagus Nerve Stimulation for Poststroke Motor Recovery: A Systematic Review and Meta-Analysis of Movement-Synchronized Neuromodulation.","authors":"Majed Aldehri, Ibrahim Serag, Mohamed Farouk, Mohamed M Elgohary, Ibrahim Alnaami","doi":"10.1016/j.neurom.2026.09.026","DOIUrl":"https://doi.org/10.1016/j.neurom.2026.09.026","url":null,"abstract":"<p><strong>Background: </strong>Closed-loop or movement-synchronized vagus nerve stimulation (VNS) has emerged as a promising neuromodulatory strategy to enhance activity-dependent neuroplasticity after stroke. Unlike conventional open-loop stimulation, closed-loop VNS is temporally coupled with motor execution, potentially improving the specificity and efficacy of motor recovery. However, clinical evidence remains fragmented, and no prior meta-analysis has specifically evaluated this approach. This study aimed to systematically assess the effectiveness and safety of closed-loop VNS for upper-limb motor recovery after stroke.</p><p><strong>Materials and methods: </strong>A systematic review and meta-analysis were conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Electronic data bases (PubMed/MEDLINE, Scopus, and Web of Science) were searched from inception to March 2026. Randomized controlled trials (RCTs) investigating movement-synchronized VNS in adult patients with a clinical diagnosis of stroke presenting with upper limb motor impairment were included. Primary outcomes were changes in Fugl-Meyer Assessment of Upper Extremity (FMA-UE) and Wolf Motor Function Test (WMFT). Data were pooled using a random-effects model, and effect sizes were expressed as mean difference (MD) or standardized mean difference (SMD) with 95% CI. Risk of bias was assessed using RoB2, and certainty of evidence was evaluated using Grading of Recommendations Assessment, Development, and Evaluation.</p><p><strong>Results: </strong>Six RCTs comprising 215 participants were included in the quantitative synthesis, with an additional cohort study included qualitatively. Closed-loop VNS demonstrated a significant improvement in FMA-UE scores compared with controls (MD = 2.33, 95% CI 0.95-3.70, p = 0.0009), although with substantial heterogeneity (I<sup>2</sup> = 89%). WMFT outcomes from four RCTs (n ≈ 177) also favored closed-loop VNS (SMD = 0.62, 95% CI 0.25-0.98, p = 0.0009) with low heterogeneity (I<sup>2</sup> = 18%). Sensitivity analyses confirmed the stability of the findings, whereas meta-regression showed no significant effect of age. The pooled adverse-event analysis of two implanted VNS trials showed no statistically significant between-group difference, although estimates were highly imprecise. Overall certainty of evidence was moderate.</p><p><strong>Conclusion: </strong>Closed-loop or movement-synchronized VNS may provide clinically meaningful improvements in upper-limb motor function after stroke; however, the available safety evidence is limited and imprecise, particularly for implanted VNS, and cannot be generalized to noninvasive transcutaneous auricular VNS.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase-Dependent Effects of Cerebellar Transcranial Alternating Current Stimulation on Lateral Vestibulospinal Tract Excitability. 小脑经颅交流电刺激对外侧前庭脊髓束兴奋性的相位依赖性影响。
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-07 DOI: 10.1016/j.neurom.2026.09.022
Osuke Shibata, Hisato Nakazono, Takanori Taniguchi, Maiko Sakamoto, Tsubasa Mitsutake
{"title":"Phase-Dependent Effects of Cerebellar Transcranial Alternating Current Stimulation on Lateral Vestibulospinal Tract Excitability.","authors":"Osuke Shibata, Hisato Nakazono, Takanori Taniguchi, Maiko Sakamoto, Tsubasa Mitsutake","doi":"10.1016/j.neurom.2026.09.022","DOIUrl":"https://doi.org/10.1016/j.neurom.2026.09.022","url":null,"abstract":"<p><strong>Objective: </strong>Transcranial alternating current stimulation (tACS) delivers a periodic electric field that can modulate neural activity in relation to the stimulation waveform. The cerebellum is intricately linked to the vestibular system in postural regulation, suggesting that the phase of cerebellar tACS may influence lateral vestibulospinal tract (LVST) excitability. We examined the phase-dependent effects of cerebellar tACS on LVST excitability by assessing changes in the soleus H-reflex amplitude during galvanic vestibular stimulation (GVS-H).</p><p><strong>Materials and methods: </strong>A single-blind, randomized, crossover study was conducted with 20 healthy adults to compare LVST excitability across four conditions: baseline, sham stimulation, peak-phase, and trough-phase cerebellar tACS (1 Hz, 1 mA peak-to-peak, 150 seconds). LVST excitability was evaluated using GVS-H, with ten trials performed under each condition.</p><p><strong>Results: </strong>GVS-H showed a significant main effect among the conditions (p < 0.001). Post hoc analyses indicated that the peak-phase condition produced significantly higher values than the baseline, trough-phase, and sham conditions (p < 0.05).</p><p><strong>Conclusions: </strong>LVST excitability differed according to the phase of the ongoing cerebellar-targeted tACS waveform. These findings provide electrophysiologic evidence of an online phase-dependent effect on vestibulospinal excitability and a physiologic basis for future phase-specific neuromodulation studies.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive Outcomes From Real-World Evidence for Vagus Nerve Stimulation Therapy: Seizure and Nonseizure 36-Month Outcomes in People With Drug-Resistant Epilepsy. 来自真实世界证据的迷走神经刺激治疗的综合结果:耐药癫痫患者36个月的癫痫发作和非癫痫发作结局
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-05 DOI: 10.1016/j.neurom.2026.09.017
Arjune Sen, Patrick Kwan, Paul Lyons, James Wheless, Jose Ferreira, Kore Liow, James Valeriano, Gholam Motamedi, Firas Fahoum, Riem El Tahry, Terence J O'Brien, Karen Keough, Jane Boggs, Ana Suller Marti, Mark Keezer, Andrea Andrade, Martin Veilleux, Kenneth A Myers, Jorge G Burneo, Ricky Lee, Muhammad Zafar, Michal Tzadok, Rhys Thomas, Katarzyna Kotulska, Youssef Al-Said, Fawzi Babtain, Saleh Baeesa, Maxine Dibué, Charles Gordon, Massimiliano Boffini, Francesca Beraldi, Katherine Eggleston, Ryan Verner, Gaia Giannicola, Kathryn Nichol
{"title":"Comprehensive Outcomes From Real-World Evidence for Vagus Nerve Stimulation Therapy: Seizure and Nonseizure 36-Month Outcomes in People With Drug-Resistant Epilepsy.","authors":"Arjune Sen, Patrick Kwan, Paul Lyons, James Wheless, Jose Ferreira, Kore Liow, James Valeriano, Gholam Motamedi, Firas Fahoum, Riem El Tahry, Terence J O'Brien, Karen Keough, Jane Boggs, Ana Suller Marti, Mark Keezer, Andrea Andrade, Martin Veilleux, Kenneth A Myers, Jorge G Burneo, Ricky Lee, Muhammad Zafar, Michal Tzadok, Rhys Thomas, Katarzyna Kotulska, Youssef Al-Said, Fawzi Babtain, Saleh Baeesa, Maxine Dibué, Charles Gordon, Massimiliano Boffini, Francesca Beraldi, Katherine Eggleston, Ryan Verner, Gaia Giannicola, Kathryn Nichol","doi":"10.1016/j.neurom.2026.09.017","DOIUrl":"https://doi.org/10.1016/j.neurom.2026.09.017","url":null,"abstract":"<p><strong>Objectives: </strong>Drug-resistant epilepsy (DRE) affects approximately one-third of all people with epilepsy and carries a disproportionate comorbidity burden. Many people with DRE are not candidates for, or do not want, resective surgery or disconnection procedures; therefore, vagus nerve stimulation (VNS) can be used for treatment. Despite its long-standing use, there is a notable lack of data regarding the newer generations of VNS Therapy devices. This study provides long-term, real-world data on the outcomes of contemporary responsive VNS Therapy devices.</p><p><strong>Materials and methods: </strong>Comprehensive Outcomes From Real-World Evidence for VNS Therapy (CORE-VNS; NCT03529045) is a large, international, observational, prospective study designed to systematically and comprehensively evaluate the clinical and safety outcomes of people with DRE who receive a contemporary VNS system as part of their treatment plan. We report seizure, nonseizure, and safety outcomes data for participants who received their first VNS Therapy implant with at least 36 months of follow-up postimplantation.</p><p><strong>Results: </strong>Initial implantation of the VNS Therapy System was performed in 531 participants, and 426 (80.2%) completed the study. Monthly seizure frequency for combined and individual seizure types was significantly reduced from baseline by the first three-month visit (p < 0.0001) and continued to improve throughout the study. At 36 months, the median percentage change in seizure frequency for all seizures reported at baseline was -76.3% (95% CI -83.33% to -66.67%, p < 0.0001), and 27.6% (n = 108/392; 95% CI 23.9% to 31.5%) of participants no longer reported baseline seizure types. Seizure freedom from all seizures reported during the study was achieved in 16.3% (n = 64/392; 95% CI 13.3% to 19.7%) of participants at the 36-month study visit.</p><p><strong>Conclusions: </strong>Results of the CORE-VNS study indicate that contemporary VNS Therapy was associated with an early and sustained benefit on seizures in participants with DRE. This reinforces adjunctive VNS Therapy as an important therapeutic option for those who cannot undergo resective surgery or disconnection procedures.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Effects of Transcutaneous Spinal Cord Stimulation on Gait Symmetry in People With Chronic Stroke. 经皮脊髓刺激对慢性脑卒中患者步态对称的急性影响。
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-05 DOI: 10.1016/j.neurom.2026.09.018
Mitchell Tillman, Nicole Veit, Ameen Kishta, Kelly McKenzie, Shreya Aalla, Jasmine Glenn-Hunt, Rushmin Khazanchi, Tyler G Petrie, Chen Yang, Richard L Lieber, Elliot Roth, Arun Jayaraman
{"title":"Acute Effects of Transcutaneous Spinal Cord Stimulation on Gait Symmetry in People With Chronic Stroke.","authors":"Mitchell Tillman, Nicole Veit, Ameen Kishta, Kelly McKenzie, Shreya Aalla, Jasmine Glenn-Hunt, Rushmin Khazanchi, Tyler G Petrie, Chen Yang, Richard L Lieber, Elliot Roth, Arun Jayaraman","doi":"10.1016/j.neurom.2026.09.018","DOIUrl":"10.1016/j.neurom.2026.09.018","url":null,"abstract":"<p><strong>Objectives: </strong>To determine whether transcutaneous spinal cord stimulation (tSCS) modulates gait symmetry after a single 25-minute bout of treadmill gait training, and to establish whether a particular combination of tSCS frequency and intensity elicits greater changes in gait symmetry.</p><p><strong>Materials and methods: </strong>In each of six sessions, 20 participants with chronic stroke received 25 minutes of treadmill gait training while they received either SHAM stimulation or one of four unique stimulation (tSCS) parameter combinations: 30 or 50 Hz frequency, and intensity at participant tolerance or 30% of minimum resting motor threshold. In each session, our primary outcomes were step length (m) and swing duration (sec) symmetry during the 10-meter Walk Test (10 MWT) PRE- and POST-treadmill training. We also computed an \"overall\" symmetry measure, the Combined Gait Asymmetry Metric (CGAM), and 10 MWT gait speed. Changes from PRE to POST-intervention intervention and how they differed among stimulation parameters were assessed via the Timepoint x Intervention interaction effect of a two-way repeated-measures analysis of variance. A complementary exploratory analysis was performed to determine individualized \"best\" vs \"worst\" stimulation parameters compared with SHAM.</p><p><strong>Results: </strong>Among the five interventions tested, we found no statistically significant difference in the change from PRE to POST in the primary outcome variables-step length symmetry (Timepoint x Intervention effect, p = 0.0564) and swing duration symmetry (p = 0.6215)-or in CGAM (p = 0.5350) or 10 MWT gait speed (p = 0.4828).</p><p><strong>Conclusions: </strong>We found that 25 minutes of tSCS plus treadmill training did not significantly change gait symmetry or speed compared with treadmill training alone. These findings also suggest that, in a single-session setting, there may not be a best frequency or intensity that is optimal for everyone. Future work should investigate whether person-specific stimulation parameters may yield single-day gait symmetry changes, as well as the potential longitudinal effects of tSCS plus gait training.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13755686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Motor Cortex Stimulation in the Treatment of Chronic Neuropathic Pain: Real-World Data on Long-Term Outcomes, Predictors of Response, and Safety. 运动皮质刺激治疗慢性神经性疼痛:长期结果、反应预测因素和安全性的真实世界数据。
IF 3.7 3区 医学
Neuromodulation Pub Date : 2026-10-05 DOI: 10.1016/j.neurom.2026.09.019
Emil Isagulyan, Evgeniy Dorokhov, Viktor Kondratyev, Alexey Tomskiy
{"title":"Motor Cortex Stimulation in the Treatment of Chronic Neuropathic Pain: Real-World Data on Long-Term Outcomes, Predictors of Response, and Safety.","authors":"Emil Isagulyan, Evgeniy Dorokhov, Viktor Kondratyev, Alexey Tomskiy","doi":"10.1016/j.neurom.2026.09.019","DOIUrl":"https://doi.org/10.1016/j.neurom.2026.09.019","url":null,"abstract":"<p><strong>Objectives: </strong>Motor cortex stimulation (MCS) has been used for chronic neuropathic pain for over 35 years, yet long-term efficacy and safety data remain extremely limited. This study aimed to present real-world data on the long-term outcomes, predictors of response, and safety of MCS in clinical practice.</p><p><strong>Materials and methods: </strong>A retrospective analysis was conducted on 20 patients (median age 52.5 years) who underwent epidural MCS implantation at a single neurosurgical center between 2004 and 2014. Indications included neuropathic pain lasting more than three months with an intensity >5 on the Numeric Rating Scale (NRS) refractory to conservative therapy. Preoperative transcranial magnetic stimulation (TMS) and functional magnetic resonance imaging with neuronavigation were used for electrode targeting. Pain intensity was assessed using a questionnaire based on the Brief Pain Inventory. Stimulation efficacy was defined as ≥50% pain reduction at the last follow-up. Statistical analysis employed nonparametric methods (Wilcoxon signed-rank test). The median follow-up was 11 years.</p><p><strong>Results: </strong>At last follow-up, median pain intensity decreased from 8 to 4 points on the NRS (p < 0.05). Long-term pain reduction ≥50% was achieved in 14 of 19 patients (73.7%). One patient was excluded from the long-term efficacy analysis due to system explantation for infection three months postoperatively. Two patients (10%) experienced a loss of efficacy over time. TMS demonstrated a positive predictive value of 71.43% but a negative predictive value of only 33.33% in predicting MCS efficacy. Infectious complications leading to system explantation occurred in two patients (10%). No seizures, hematomas, or permanent neurologic deficits were observed.</p><p><strong>Conclusions: </strong>MCS provides clinically significant long-term pain reduction in 70% of patients with chronic neuropathic pain, alongside subjectively improved quality of life and reduced analgesic requirements. A single ineffective TMS session should not preclude MCS implantation because the negative predictive value is low. Larger randomized controlled trials are warranted to verify these findings.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书